Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small lump or bump at the injection site is one of the most common things people notice after their first few Wegovy doses. In most cases it is a local tissue reaction, not a sign that anything has gone wrong with the medicine itself. That said, knowing what to watch for matters. This page explains why these lumps form, how to tell a normal reaction from one that needs attention, and what injection habits reduce the chances of them appearing in the first place. Wegovy (semaglutide) is a prescription-only medicine, so if you have any concern about what you are experiencing, your prescribing clinician is the right first call.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you inject Wegovy, a small volume of fluid goes into the fatty tissue just beneath the skin. The body's immediate response is sometimes a localised swelling as nearby capillaries react and a tiny amount of fluid accumulates around the deposit. This is not the medicine leaking or pooling incorrectly in most cases; it is simply the subcutaneous layer responding to a foreign substance being introduced.
Semaglutide sits in an aqueous carrier solution, and at colder temperatures the liquid is slightly more viscous. Injecting a pen taken straight from the fridge can make the medicine push through the tissue more abruptly, which some people notice as a firmer sensation and a more visible lump afterwards. Allowing the pen to sit at room temperature for around 30 minutes before use is a practical step worth trying, though for exact storage guidance always follow the Patient Information Leaflet that comes with your pen.
The NHS medicines page for semaglutide lists injection-site reactions, including swelling and nodules at the site, as known and recognised effects of the medicine. The fact that a lump appears after a Wegovy injection does not mean your body is rejecting the treatment. Most resolve on their own within a day or two, leaving no trace. If you want more background on how injection-site reactions compare across the main injection points, our page on choosing where to inject Wegovy covers the differences in tissue depth and absorption by site.
A question our prescribers hear most weeks is some version of: "I've got a hard lump where I injected and I'm not sure if it's normal." The honest answer is that most of the time it is, but there are specific features worth knowing.
A normal site reaction is typically soft or only slightly firm, pea-sized or smaller, not red beyond a faint blush, and not warm to touch. It settles within one to three days and does not increase in size after the first few hours. You may notice mild itching around the site, which is also a recognised response.
Signs that warrant contact with your prescriber or GP are different. A lump that is growing rather than shrinking over 48 hours, one that becomes noticeably red, hot or significantly tender, or one accompanied by fever, needs to be assessed in person. Infection at an injection site, while uncommon with correct technique, does occur occasionally and is treated with antibiotics rather than watchful waiting. A lump that is still clearly present after two weeks, even if painless, is also worth mentioning at your next clinical review. You can also find structured guidance on this distinction at our lump under the skin after Wegovy injection page.
If you are ever unsure, contacting your prescriber is the right call. At nume, aftercare support is available seven days a week precisely for moments like this. You can reach the team through our contact page.
Most injection-site lumps are preventable with small, consistent changes to how the injection is given. Technique matters more than people expect.
Rotation is the most important factor. Injecting into the same few millimetres of skin repeatedly causes localised tissue changes, including lipohypertrophy (a thickening of the fatty layer that can look and feel like a persistent lump and also affects how reliably the medicine is absorbed). Using all three licensed sites in a deliberate rotation and moving at least a couple of centimetres from the previous spot within each site distributes the weekly impact across a larger area of tissue. Our full Wegovy injection technique guide walks through this in detail.
A few other habits make a consistent difference. Insert the needle at the angle described in your pen instructions rather than half-pressing and pulling back. Keep the pen pressed flat against the skin for the full injection period, usually indicated by a click or a visible window change depending on the pen type, before removing it. Pulling out early can mean some of the medicine tracks back up the needle channel and deposits too close to the skin surface, where it disperses less well. Wiping the area with an alcohol swab before injecting also reduces the minor infection risk that can turn a small reaction into a more stubborn lump.
Occasionally a lump forms because the needle is blunt from reuse. Wegovy pens are designed for single use per injection; changing to a fresh needle each time removes this as a variable. For anyone building a reliable kit, replacement needles are available separately.
If you experience a reaction you think others on Wegovy should know about, the MHRA's Yellow Card scheme lets patients report suspected side effects directly. This is genuinely useful: post-marketing surveillance through Yellow Card is how regulators track real-world safety signals that clinical trials can miss, and Wegovy carries a Black Triangle designation precisely because additional monitoring is ongoing.
The NHS semaglutide medicines page lists the full range of recognised side effects and gives clear guidance on which symptoms warrant urgent medical attention. Injection-site reactions appear there under the common-effects category, which is a useful frame for keeping the lump situation in proportion.
For questions about cost, our Wegovy pricing page sets out what private treatment through a regulated service covers. And if you are weighing up whether Wegovy is the right option for you at all, our weight-loss treatment overview explains how the licensed medicines compare and what a clinical assessment involves, including how long after injecting Wegovy it typically starts to work. When you are ready, you can start your free consultation and have your answers reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.